Testing for noninferiority of binomial distributions referring to a modified equivalence region with piecewise linear boundary

References

• Food and Drug Administration FDA. Division of anti-infective drug products. Points to consider. Rockville, MD: Center for Drug Evaluation and Research CDER; 1992.
   Google Scholar
• Röhmel J. Therapeutic equivalence investigations: statistical considerations. Stat Med. 1998;17:1703–1714. doi: 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1703::AID-SIM972>3.0.CO;2-G
   PubMed Web of Science ®Google Scholar
• Phillips KF. A new test of non-inferiority for anti-infective trials. Stat Med. 2003;22:201–212. doi: 10.1002/sim.1122
   PubMed Web of Science ®Google Scholar
• Röhmel J, Mansmann U. Unconditional non-asymptotic one-sided tests for independent binomial proportions when the interest lies in showing non-inferiority and/or superiority. Biom J. 1999;41:149–170. doi: 10.1002/(SICI)1521-4036(199905)41:2<149::AID-BIMJ149>3.0.CO;2-E
   Web of Science ®Google Scholar
• Kim MY, Xue X. Likelihood ratio and a Bayesian approach were superior to standard noninferiority analysis when the noninferiority margin varied with the control event rate. J Clin Epidemiol. 2004;57:1253–1261. doi: 10.1016/j.jclinepi.2004.05.005
   PubMed Web of Science ®Google Scholar
• Röhmel J. Statistical considerations of FDA and CPMP rules for the investigation of new anti-bacterial products. Stat Med. 2001;20:2561–2571. doi: 10.1002/sim.729
   PubMed Web of Science ®Google Scholar
• D'Agostino Sr RB, Garo JM, Sullivan LM. Non-inferiority trials: design concepts and issues – the encounters of academic consultants in statistics. Stat Med. 2002;22:169–186. doi: 10.1002/sim.1425
   Web of Science ®Google Scholar
• Committee for Proprietary Medicinal Products (CPMP). Note for guidance on evaluation of medicinal products indicated for treatment of bacterial infections [CPMP/EWP/558/95 rev1]. London: European Agency for the Evaluation of Medicinal Products (EMEA); 2004.
   Google Scholar
• Sorbello A, Komo S, Valappil T, Nambiar S. Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia. Clin Infect Dis. 2010;51(S1):S36–S41. doi: 10.1086/653038
   PubMed Web of Science ®Google Scholar
• Berger RL. Multiparameter hypothesis testing and acceptance sampling. Technometrics. 1982;24:295–300. doi: 10.2307/1267823
   Web of Science ®Google Scholar
• Wellek S. Testing statistical hypotheses of equivalence and noninferiority. 2nd ed. Boca Raton, FL: Chapman & Hall/CRC; 2010.
   Google Scholar
• Wellek S. Statistical methods for the analysis of two-arm non-inferiority trials with binary outcomes. Biom J. 2005;47:48–61. doi: 10.1002/bimj.200410090
   PubMed Web of Science ®Google Scholar
• Vestrup EM. The theory of measures and integration. Hoboken, NJ: Wiley & Sons; 2003.
   Google Scholar
• Davis PJ, Rabinowitz P. Methods of numerical integration. New York, NY: Academic Press; 1975.
   Google Scholar
• Abramowitz M, Stegun I. Handbook of mathematical functions. New York, NY: Dover Publications, Inc.; 1965.
   Google Scholar
• Lehmann EL, Romano JP. Testing statistical hypotheses. 3rd ed. New York, NY: Springer; 2005.
   Google Scholar
• Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unit relative risk. Stat Med. 1990;9:1447–1454. doi: 10.1002/sim.4780091208
   PubMed Web of Science ®Google Scholar
• Cox DR, Hinkley DV. Theoretical statistics. London: Chapman & Hall; 1974.
   Google Scholar
• Ueno H, Ioka T, Ikeda M, Ohkawa S, Yanagimoto H, Boku N, Fukutomi A, Sugimori K, Baba H, Yamao K, Shimamura T, Sho M, Kitano M, Chen A-L, Mizumoto K, Chen J-S, Furuse J, Funakoshi A, Hatori T, Yamaguchi T, Egawa S, Sato A, Ohashi Y, Okusaka T, Tanaka M. Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study. J Clin Oncol. 2013;31:1640–1648. doi: 10.1200/JCO.2012.43.3680
   PubMed Web of Science ®Google Scholar
• Lange S, Freitag G. Choice of delta: requirements and reality – results of a systematic review. Biom J. 2005;47:12–27. doi: 10.1002/bimj.200410085
   PubMed Web of Science ®Google Scholar
• CDER & CBER/FDA Guidance for Industry. Non-inferiority clinical trials. Rockville, MD: FDA Administration; 2010.
   Google Scholar